Clinical pharmacokinetics of new antiepileptic drugs

This publication has 100 references indexed in Scilit:

• Vigabatrin‐induced decrease in serum phenytoin concentration does not involve a change in phenytoin bioavailability
  British Journal of Clinical Pharmacology, 1993
• [3H]Gabapentin may label a system-L-like neutral amino acid carrier in brain
  European Journal of Pharmacology: Molecular Pharmacology, 1993
• The pharmacokinetics of oxcarbazepine and its active metabolite 10‐hydroxy‐carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid
  British Journal of Clinical Pharmacology, 1993
• Pharmacokinetics of Vigabatrin Following Single and Multiple Oral Doses in Normal Volunteers
  The Journal of Clinical Pharmacology, 1993
• Localization of [3H]gabapentin to a novel site in rat brain: autoradiographic studies
  European Journal of Pharmacology: Molecular Pharmacology, 1993
• Characterisation of [3H]gabapentin binding to a novel site in rat brain: homogenate binding studies
  European Journal of Pharmacology: Molecular Pharmacology, 1993
• Influence of co-medication on the metabolism of valproate
  International Journal of Clinical Pharmacy, 1992
• Safety, Tolerance and Pharmacokinetics of Intravenous Doses of the Phosphate Ester of 3‐Hydroxymethyl‐5,5‐Diphenylhydantoin: A New Prodrug of Phenytoin
  The Journal of Clinical Pharmacology, 1988
• Pharmacokinetics of Stiripentol in Normal Man: Evidence of Nonlinearity
  The Journal of Clinical Pharmacology, 1983
• EMBRYOTOXICITY TESTING OF VALPROIC ACID
  The Lancet, 1983